Researchers Say After Implementation Of The 13-Valent PCV13, Most Non-PCV13 Serotypes May Have Low IPD Potential

Infectious Disease Advisor (8/27, van Paridon) reports researchers found “after implementation of the 13-valent pneumococcal conjugate vaccine (PCV13), most non-PCV13 serotypes had low invasive pneumococcal disease (IPD) potential.” The findings were publ...